Abiomed, Inc.ABMDNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+17.4%
5Y CAGR+17.9%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+17.4%/yr
vs +21.9%/yr prior
5Y CAGR
+17.9%/yr
Consistent
Acceleration
-4.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2022 | 48.51% | +66.5% |
| 2021 | 29.14% | -4.8% |
| 2020 | 30.62% | +2.1% |
| 2019 | 29.99% | +8.3% |
| 2018 | 27.70% | +30.1% |
| 2017 | 21.29% | +3.2% |
| 2016 | 20.63% | +52.1% |
| 2015 | 13.56% | +131.7% |
| 2014 | 5.86% | -52.0% |
| 2013 | 12.19% | - |